Yale University

Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: A model-based analysis in Côte d'Ivoire.

TitleClinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: A model-based analysis in Côte d'Ivoire.
Publication TypeJournal Article
Year of Publication2014
AuthorsOuattara, Eric N., Eric L. Ross, Yazdan Yazdanpanah, Angela Y. Wong, Marion Robine, Elena Losina, Raoul Moh, Rochelle P. Walensky, Christine Danel, David A. Paltiel, Serge P. Eholié, Kenneth A. Freedberg, and Xavier Anglaret
JournalJournal of acquired immune deficiency syndromes (1999)
Date Published2014 Apr 11
ISSN1944-7884
AbstractIn sub-Saharan Africa, HIV-infected adults who fail 2-line antiretroviral therapy (ART) often do not have access to 3-line ART. We examined the clinical impact and cost-effectiveness of making 3-line ART available in Côte d'Ivoire.
DOI10.1097/QAI.0000000000000166
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links